XBiotech Inc.
XBITNASDAQHealthcare● Active
$2.37
+$0.00(+0.00%)
Market Cap$72255922
P/E Ratio—
52W High$3.61
52W Low$2.09
XBiotech Inc. (XBIT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
XBIT · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.18
Est. $0.03 · -700.0%
Revenue
—
Est. $0.01B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS
XBIT reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.00
Rev. $1.80B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.00
Rev. Est.$1.80B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | $0.03 | -$0.18 | -700.0% | — | $0.01B | — |
| ▼ Q1 FY2026 | Mar 13, 2026 | $0.04 | -$0.88 | -2300.0% | — | $0.01B | — |
| — Q4 FY2025 | Nov 12, 2025 | — | -$0.20 | — | — | — | — |
| — Q3 FY2025 | Aug 13, 2025 | — | -$0.06 | — | — | — | — |
| — Q2 FY2025 | May 14, 2025 | — | -$0.36 | — | — | — | — |
| — Q1 FY2025 | Mar 18, 2025 | — | -$0.34 | — | — | — | — |
| — Q4 FY2024 | Nov 13, 2024 | — | -$0.16 | — | — | — | — |
| — Q3 FY2024 | Aug 12, 2024 | — | -$0.43 | — | — | $0.01B | — |
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$0.18
EPS Est.
$0.03
EPS Surpr.
-700.0%
Revenue
—
Q1 FY2026
Mar 13, 2026Miss
EPS Actual
-$0.88
EPS Est.
$0.04
EPS Surpr.
-2300.0%
Revenue
—
Q4 FY2025
Nov 12, 2025
EPS Actual
-$0.20
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 13, 2025
EPS Actual
-$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 14, 2025
EPS Actual
-$0.36
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 18, 2025
EPS Actual
-$0.34
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 13, 2024
EPS Actual
-$0.16
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 12, 2024
EPS Actual
-$0.43
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2027 | $0.02 | $0.02 | $0.02 | 1 |
| Q2 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q1 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q4 FY2026 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2026 | $0.02 | $0.02 | $0.02 | 1 |
| Q2 FY2026 | $0.03 | $0.03 | $0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -700.0% | $2.50 | $2.50 | +0.00% |
| ▼ Q1 FY2026 | Mar 13, 2026 | -2300.0% | $2.34 | $2.31 | -1.28% |
| — Q4 FY2025 | Nov 12, 2025 | — | $2.94 | $2.77 | -5.78% |
| — Q3 FY2025 | Aug 13, 2025 | — | $2.97 | $3.14 | +5.72% |
| — Q2 FY2025 | May 14, 2025 | — | $2.98 | $2.88 | -3.36% |
| — Q1 FY2025 | Mar 18, 2025 | — | $3.52 | $3.42 | -2.84% |
| — Q4 FY2024 | Nov 13, 2024 | — | $7.09 | $7.10 | +0.14% |
| — Q3 FY2024 | Aug 12, 2024 | — | $6.59 | $6.54 | -0.76% |
Q2 FY2026+0.00%
Report Date
May 14, 2026
EPS Beat/Miss
-700.0%
Price Before
$2.50
Price After
$2.50
Q1 FY2026-1.28%
Report Date
Mar 13, 2026
EPS Beat/Miss
-2300.0%
Price Before
$2.34
Price After
$2.31
Q4 FY2025-5.78%
Report Date
Nov 12, 2025
EPS Beat/Miss
—
Price Before
$2.94
Price After
$2.77
Q3 FY2025+5.72%
Report Date
Aug 13, 2025
EPS Beat/Miss
—
Price Before
$2.97
Price After
$3.14
Q2 FY2025-3.36%
Report Date
May 14, 2025
EPS Beat/Miss
—
Price Before
$2.98
Price After
$2.88
Q1 FY2025-2.84%
Report Date
Mar 18, 2025
EPS Beat/Miss
—
Price Before
$3.52
Price After
$3.42
Q4 FY2024+0.14%
Report Date
Nov 13, 2024
EPS Beat/Miss
—
Price Before
$7.09
Price After
$7.10
Q3 FY2024-0.76%
Report Date
Aug 12, 2024
EPS Beat/Miss
—
Price Before
$6.59
Price After
$6.54
Avg Miss Reaction-0.64%
Beat Rate0 / 8 quarters
Largest Move-5.78% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: XBIT ends December
XBiotech Inc. (XBIT) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.18 — missing the analyst consensus of $0.03 by -700.0%. The next XBIT earnings date is expected around September 1, 2026.
Each quarter, investors track XBIT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. XBIT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
XBIT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
XBIT earnings · 5 questionsXBiotech Inc.'s next earnings report is expected around September 1, 2026. XBIT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; XBIT historically reports after market close (AMC).
XBIT earnings datewhen is XBIT earningsXBIT next earnings datewhen does XBIT report earningsXBIT earnings calendar
▸ Source: FMP · XBiotech Inc. SEC filings · US GAAP · XBiotech Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026